Advertisement

The effect of gallopamil p.o. on global and regional ventricular function in patients with coronary heart disease

  • G. Großmann
  • M. Stauch
  • A. Schmidt
  • J. Waitzinger
Conference paper

Abstract

On the basis of its pharmacodynamic profile, gallopamil, a methoxy derivative of verapamil, is a specific calcium antagonist (8). Its anti-anginal efficacy has been demonstrated in a number of trials involving patients with coronary heart disease (CHD) in which the assessment criterion was the exercise ECG (6,12,16, 21, 23, 35, 37). However, a study using emission tomography has also shown that myocardial microperfusion improves under gallopamil (10).

Keywords

Negative Inotropic Effect Radionuclide Angiography Ischaemia Group Regional Motility Fourier Amplitude 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adam WE, Stauch M (1985) Radionuclide Methods. In: Abshagen U (ed) Clinical Pharmacology of Antianginal Drugs. Springer, Berlin Heidelberg New York Tokyo, pp. 213–237CrossRefGoogle Scholar
  2. 2.
    Adam WE, Tarkowska F, Bitter F, Stauch M, Geffers H (1979) Equilibrium (gated) radionuclide ventriculography. Cardiovasc Radiol 2: 161–173PubMedCrossRefGoogle Scholar
  3. 3.
    Austin EH, Cobb FR, Coleman RE, Jones RH (1982) Prospective Evaluation of Radionuclide Angiocardiography for the Diagnosis of Coronary Artery Disease. Am J Cardiol 50:1212–1216PubMedCrossRefGoogle Scholar
  4. 4.
    Bonow RO, Leon MB, Rosing DR, Kent KM, Lipson LC, Bacharach SL, Green MV, Epstein SE (1981) Effects of Verapamil and Propranolol on Left Ventricular Systolic Function and Diastolic Filling in Patients with Coronary Artery Disease: Radionuclide Angiographic Studies at Rest and During Exercise. Circulation 65:1337–1350CrossRefGoogle Scholar
  5. 5.
    Borer JS, Kent KM, Bacharach SL, Green MV, Rosing DR, Seides SF, Epstein SE, Johnston GS (1979) Sensitivity. SpecifiCity and Predictive Accuracy of Radionuclide Cineangiography During Exercise in Patients with Coronary Artery Disease. Circulation 60:572–580PubMedGoogle Scholar
  6. 6.
    Bouzo H (1983) Gallopamil und Propranolol bei stabiler belastungsinduzierter Angina pectoris. Therapiewoche 33:6465–6468Google Scholar
  7. 7.
    Colucci WS, Fifer MA, Lorell BH,Wynne J (1985) Calcium Channel Blockers in Congestive Heart Failure: Theoretic Considerations and Clinical Experience. Am J Med 78, Suppl 2B:9–17PubMedCrossRefGoogle Scholar
  8. 8.
    Fleckenstein A, Fleckenstein B, Späh F, Byon YK (1983) Gallopamil (D600) — ein Kalziumantagonist von hoher Wirkungsstärke und Spezifität. Effekt auf Myocard und Schrittmacher. In: Kaltenbach M, Hopf R (eds) Gallopamil. Springer, Berlin Heidelberg New York Tokyo, pp. 1–34CrossRefGoogle Scholar
  9. 9.
    Gibbons RJ, Morris KG, Lee K, Coleman RE, Cobb FR (1984) Assessment of Regional Left Ventricular Function Using Gated Radionuclide Angiography. Am J Cardiol 54:294–300PubMedCrossRefGoogle Scholar
  10. 10.
    Gutmann M, Eichstätt H (1985) Tomoszintigraphische Untersuchungen zur myokardialen Mikro-perfusion unter dem Kalziumantagonisten Gallopamil. Herz/Kreislauf 7:363–368Google Scholar
  11. 11.
    Hecht HS, Josephson MA, Hopkins JM, Singh BN (1982) Reproducibility of equilibrium radionuclide ventriculography in patients with coronary artery disease: Response of left ventricular ejection fraction and regional wall motion to supine bicycle exercise. Am Heart J 104:567–574PubMedCrossRefGoogle Scholar
  12. 12.
    Hopf R, Drews H, Kaltenbach M (1984) Die antianginöse Wirkung von Gallopamil im Vergleich mit einem anderen Calciumantagonisten und Placebo. Z Kardiol 73:578–585PubMedGoogle Scholar
  13. 13.
    Jeremy R, Tokuyasu Y, Coong CYP, Bautovich G, Hutton BF, Shen W-F, Kelly DT, Harris PJ (1985) The reproducibility of nongeometric analysis of cardiac output and left ventricular volume by radionuclide angiography. Am Heart J 110:1020–1026PubMedCrossRefGoogle Scholar
  14. 14.
    Johnston DL, Gebhardt VA, Donald A, Kostuk WJ (1983) Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography. Circulation 68:1280–1289PubMedCrossRefGoogle Scholar
  15. 15.
    Hecht HS, Hopkins JM, Singh BN (1981) Oral Verapamil vs Propranolol in Coronary Artery Disease: Evaluation of Left Ventricular Function by Exercise Radionuclides Ventriculography. Am J Cardiol 47:463CrossRefGoogle Scholar
  16. 16.
    Khurmi NS, O’Hara MJ, Bowles MJ, Subramanian VB, Raftery EB (1984) Randomized Double-Blind Comparison of Gallopamil and Propranolol in Stable Angina Pectoris. Am J Cardiol 53:684–688PubMedCrossRefGoogle Scholar
  17. 17.
    Kovach AGB, Ligeti L, Bakos M, Rubanyi G, Koller A (1983) In-vitro- und In-vivo-Unter-suchungen über die Wirkung von Gallopamil and Koronargefäßen. In: Kaltenbach M, Hopf R (eds.) Gallopamil. Springer, Berlin Heidelberg New York, pp. 61–68CrossRefGoogle Scholar
  18. 18.
    Krayenbühl HP, Hess OM, Hirzel HO, Carrol JD (1984) Hämodynamik unter Ischämie. Systolische Phase. Z Kardiol 73, Suppl 2:119–126PubMedGoogle Scholar
  19. 19.
    Low RI, Takeda P, Mason DT, DeMaria AN (1982) The Effects of Channel Blocking Agents on Cardiovascular Function. Am J Cardiol 49:547–553PubMedCrossRefGoogle Scholar
  20. 20.
    Maddox DE, Wynne J, Uren R, Parker JA, Idoine J, Siegel LC, Neill JM, Cohn PF, Holman BL (1979) Regional Ejection Fraction: A Quantitative Radionuclide Index of Regional Left Ventricular Performance. Circulation 59:1001–1009PubMedGoogle Scholar
  21. 21.
    Mitrovic V, Niemelä L, Neuss H, Schlepper M (1982) Zur antianginösen Wirkung des Kalziuman-tagonisten Gallopamil. Herz/Kreislauf 11:611–616Google Scholar
  22. 22.
    Pfisterer M, Glaus L, Burkart F (1983) Comparative Effects of Nitroglycerin, Nifedipine and Metoprolol on Regional Left Ventricular Function in Patients with One-vessel Coronary Disease. Circulation 67:192–301CrossRefGoogle Scholar
  23. 23.
    Rettig G, Sen S (1983) Akut- und Langzeiteffekte von Gallopamil bei Patienten mit stabiler Angina pectoris. In: Kaltenbach M, Hopf R (eds.): Gallopamil. Springer, Berlin Heidelberg New York Tokyo, pp. 141–147CrossRefGoogle Scholar
  24. 24.
    Richter P, Sigel H, Nechwatal W, Adam WE, Stauch M (1986) Vergleich der enddiastolischen Volumina des linken Ventrikels, bestimmt mittels der Radionuklidventrikulographie, der Kontrast-mittelventrikulographie und einer geometrieunabhängigen Methode. Z Kardiol 75:107–112PubMedGoogle Scholar
  25. 25.
    Salel AF, Berman DS, DeNardo GL, Mason DT (1976) Radionuclide Assessment of Nitroglycerin Influence on Abnormal Left Ventricular Segmental Contraction in Patients with Coronary Heart Disease. Circulation 53:975–982PubMedGoogle Scholar
  26. 26.
    Sauer E, Sebening H, Hör G, Lutilsky L, Dressier J, Bofilias I, Weber N, Pabst HW, Blömer H (1978) Nichtinvasive Erfassung der Dynamik des linken Ventrikels. Dtsch Med Wochenschr 103:1199–1206PubMedCrossRefGoogle Scholar
  27. 27.
    Schneider RM, Roberts KB, Morris KG, Stanfield JA, Cobb FR (1984) Relation Between Radionuclide Angiographic Regional Ejection Fraction and Left Ventricular Regional Ischemia in Awake Dogs. Am J Cardiol 53:294–301PubMedCrossRefGoogle Scholar
  28. 28.
    Schneider RM, Weintraub WS, Klein LW, Seelaus PA, Agarwal JB, Helfant RH (1986) Rate of Left Ventricular Functional Recovery by Radionuclide Angiography after Exercise in Coronary Artery Disease. Am J Cardiol 57:927–932PubMedCrossRefGoogle Scholar
  29. 29.
    Sebening H, Sauer E (1983) Beeinflussung der Koronararterien und Hämodynamik durch Gallopamil. In: Kaltenbach M, Hopf R (eds) Gallopamil. Springer, Berlin Heidelberg New York Tokyo, pp. 117–118CrossRefGoogle Scholar
  30. 30.
    Sesto M, Ivanic R, Custovic F (1983) Die Wirkung von Gallopamil auf die Hämodynamik bei Patienten mit KHK. In: Kaltenbach M, Hopf R (eds) Gallopamil. Springer, Berlin Heidelberg New York Tokyo, pp. 97–100CrossRefGoogle Scholar
  31. 31.
    Simon R (1984) Kalziumantagonisten. Wirkung auf periphere und koronare Hämodynamik. Z Kardiol 73, Suppl. 2:79–88PubMedGoogle Scholar
  32. 32.
    Slutsky R, Karliner J, Battler A (1979) Reproducibility of ejection fraction and ventricular volume by gated radionuclide angiography after myocardial infarction. Radiology 132:155PubMedGoogle Scholar
  33. 33.
    Stauch M, Haerer W, Rogg-Dussler G, Sigel H, Adam WE (1985) Effects of molsidomine on regional contraction and global function of the left ventricle. Am Heart J 109: 653–658PubMedCrossRefGoogle Scholar
  34. 34.
    Stauch M, Richter P, Roth J, Herrmann T, Schmutz C, Henze E, Adam WE (1986) Cardiac effects of pentoxylline in patients with coronary heart disease at rest and during exercise. Herz/Kreislauf 10:489–495Google Scholar
  35. 35.
    Subramanian VB (1985) Vergleichende Untersuchung von Gallopamil und 6 weiteren Kalziumantagonisten mit Placebo und Propranolol bei Patienten mit chronisch stabiler Angina pectoris. Herz/ Kreislauf 1:9–20Google Scholar
  36. 36.
    Tan ATH, Sadick N, Kelly DT, Harris PJ, Freedman SB, Bautovich G (1982) Verapamil in Stable Effort Angina: Effects on Left Ventricular Function Evaluated With Exercise Radionuclide Ventriculography. Am J Cardiol 49:425–430PubMedCrossRefGoogle Scholar
  37. 37.
    Theisen F, Jahrmärker H (1983) Wirkung von Gallopamil (D600) auf das Belastungs-EKG bei koronarer Herzerkrankung. In: Kaltenbach M, Hopf R (eds) Gallopamil. Springer, Berlin Heidelberg New York Tokyo, pp. 120–126CrossRefGoogle Scholar
  38. 38.
    Weintraub WS, Hattori S, Agrarwal JB, Bodenheimer MM, Banka VS, Helfant RH (1983) Contrasting effects of nifedipine and verapamil on myocardium and vascular smooth muscle at two levels of coronary occlusion in the dog. Am Heart J 106:1347–1352PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt 1989

Authors and Affiliations

  • G. Großmann
    • 1
    • 3
  • M. Stauch
    • 1
  • A. Schmidt
    • 1
  • J. Waitzinger
    • 2
  1. 1.Department of Cardiovascular and Respiratory MedicineUniversity of UlmGermany
  2. 2.Department of Nuclear Medicine, Clinical CentreUniversity of UlmDeutschland
  3. 3.Sektion Kardiologie, Angiologie und PulmonologieZentrum für Innere MedizinUlmGermany

Personalised recommendations